Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB1 | P08588 | 5/20 | 0.50 |
| ▸ | LMNA | P02545 | 4/20 | 0.50 |
| ▸ | ADRB2 | P07550 | 4/20 | 0.50 |
| ▸ | SLC6A2 | P23975 | 4/20 | 0.50 |
| ▸ | SLC6A4 | P31645 | 4/20 | 0.50 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.50 |
| ▸ | TSHR | P16473 | 2/20 | 0.50 |
| ▸ | HTR1A | P08908 | 1/20 | 0.50 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.50 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.50 |
| ▸ | CYP3A4 | P08684 | 5/20 | 0.49 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 3/20 | 0.33 |
| ▸ | KCNH2 | Q12809 | 2/20 | 0.33 |
| ▸ | RECQL | P46063 | 4/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.31 |
| ▸ | MAPT | P10636 | 3/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11129369 | 0.98 | CYP3A4 (0.51) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| Hydrochloric Acid SCHEMBL28575084 | 0.79 | KDM4E (0.34) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| Tert-Butylamine SCHEMBL10335790 | 0.73 | ADRB1 (0.53) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL8368382 | 0.73 | ADRB2 (0.53) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL11182115 | 0.72 | ADRB1 (0.47) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL29290531 | 0.71 | ADRB1 (0.50) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL11297642 | 0.70 | — | — | |
| SCHEMBL4336582 | 0.69 | CYP3A4 (0.48) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL19179701 | 0.67 | ADRB2 (0.46) | ADRB1LMNAADRB2SLC6A2SLC6A4 | |
| SCHEMBL19181766 | 0.67 | ADRB2 (0.46) | ADRB1LMNAADRB2SLC6A2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20050261214-A1 | Complexes for transferring substances of interest into a cell | TRANSGENE S.A. (FR) | 2005-11-24 | — | — | US | disclosed |
| EP-1389182-A1 | COMPLEXES FOR TRANSFERRING SUBSTANCES OF INTEREST INTO A CELL | TRANSGENE S.A. (FR) | 2004-02-18 | — | — | EP | disclosed |
| WO-2002092554-A1 | COMPLEXES FOR TRANSFERRING SUBSTANCES OF INTEREST INTO A CELL | TRANSGENE S.A. (FR) | 2002-11-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050261214-A1 | Complexes for transferring substances of interest into a cell | CD44, EPCAM, ANXA3 | ADRB1 3780/4885LMNA 674/4885ADRB2 3436/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.